Skip to content

China Sinochem Syngenta Group Trading

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2021

    Syngenta Faces US Paraquat Parkinson's Suits; RMB 65 Billion A-Share IPO Withdrawn

    Syngenta faces thousands of lawsuits from US farmers alleging its paraquat herbicide caused Parkinson's disease and other conditions; the company says there is insufficient causal evidence. Its Shanghai Stock Exchange IPO seeking to raise RMB 65 billion lasted nearly three years and was withdrawn in March 2024; Reuters reported that regulators suggested withdrawal due to weak markets. Litigation ongoing; IPO terminated.